Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non–nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group-Reference-Cited by-同舟云学术

Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non–nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group

Published:2006-10 Issue:10 Volume:17 Page:1560-1567
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fountzilas G.,Papakostas P.,Dafni U.,Makatsoris T.,Karina M.,Kalogera-Fountzila A.,Maniadakis N.,Aravantinos G.,Syrigos K.,Bamias A.,Christodoulou C.,Economopoulos T.,Kalofonos H.P.,Nikolaou A.,Angouridakis N.,Stathopoulos G.,Bafaloukos D.,Pavlidis N.,Daniilidis J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/10/1560/649564/mdl151.pdf

Reference20 articles.

1. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck;Jacobs;J Clin Oncol,1992

2. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study;Forastiere;J Clin Oncol,1992

3. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

4. Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group;Gibson Michael;J Clin Oncol,2005

5. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group Trial (PA 390);Forastiere;Cancer,1998

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies;Cancer Chemotherapy and Pharmacology;2022-08-03

2. Chemotherapy and chemo-resistance in nasopharyngeal carcinoma;European Journal of Medicinal Chemistry;2020-12

3. Systemic Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma- A Systematic Review and Meta-Analysis;Critical Reviews in Oncology/Hematology;2020-09

4. Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma;Expert Review of Anticancer Therapy;2018-07-16

5. Eukaryotic translation initiation factor 5A-2 involves in doxorubicin-induced epithelial-mesenchymal transition in oral squamous cell carcinoma cells;Journal of Cancer;2018